Satilmis, H., Denis, A., Verheye, E., Bruyne, E. D., Menu, E., Törngren, M., Eriksson, H., Vanderkerken, K., Veirman, K. D. (2025). IgG2a-formatted 4-1BB agonism combined with S100A9 inhibition enhances T cell activation and tumor control in a preclinical model of multiple myeloma. Blood. https://doi.org/10.1182/blood-2025-5696